UCSF 16th Annual Updates in Inflammatory Bowel Disease

This symposium will address advances in the medical and surgical management of Crohn’s disease and ulcerative colitis including novel therapies and optimization of patient’s medications in use. The organizers will also address patient safety concerns including adverse events of therapy, prevention of opportunistic infections, and substance use counseling.

On the agenda:

• Genetic, Environmental, and Microbiome Interactions in IBD
• Can We Predict Who Will Get IBD and How Severe It Will Be?
• The Role of Diet in Causing and Treating IBD
• Guidelines: Update in Management of IBD Emerging Therapies in IBD
• Safety Updates – What to Expect and How to Monitor
• The Patient with Obstructive Symptoms: When to Operate
• Checkpoint Inhibitor Colitis
• Biosimilars – Are We There Yet?
• Counseling Patients on Tobacco, Alcohol, and Marijuana Use in IBD
• Prevention of Infection Prior to IBD Therapy – Shingles, HBV, and Tuberculosis
• Hot Topics in IBD: A Review of Practice changing Data

Format: Lectures, Questions to the Panel, Medical Case Presentations and Post-Test.

10 AMA PRA Category 1 Credits™ – maximum

10 ABIM MOC points